Medications for Hormone Receptor Positive Her2 Negative Breast Cancer

1 result
  • piqray - alpelisib tablet

    (Alpelisib)
    Novartis Pharmaceuticals Corporation
    PIQRAY is used with fulvestrant to treat adults with HR-positive, HER2-negative, PIK3CA-mutated advanced or metastatic breast cancer, after progression on an endocrine-based regimen, as detected by an FDA-approved test.